# AiM Medical Robotics

> AiM Medical Robotics is a Worcester, Massachusetts medical device company building a portable, MRI-compatible surgical robot that lets neurosurgeons operate under continuous, real-time MRI guidance. Spun out of Gregory Fischer's Automation and Interventional Medicine (AIM) lab at Worcester Polytechnic Institute, the platform aims to make procedures such as deep brain stimulation lead placement, biopsy, tumor ablation and targeted drug delivery faster, more precise and less variable - reducing procedure time by up to 50% and expanding access to advanced neurosurgical care.

- **Founded:** 2018
- **Headquarters:** Worcester, Massachusetts, United States
- **Founders:** Gregory S. Fischer (Co-Founder, President & CEO), Julie G. Pilitsis (Co-Founder & Chair of Medical Advisory Board)
- **Team size:** 23 employees
- **Products:** Portable MRI-Compatible Surgical Robot, MRI-Guided Deep Brain Stimulation (DBS) Lead Placement, Cranial Intervention Suite, Siemens MAGNETOM Software Interface
- **Notable:** Developed the first MRI-compatible surgical robot to enter human clinical trials for in-bore neurosurgery, Closed $8.1M Series A in September 2025; ~$13.1M total funding raised, Completed cadaver trial for bilateral DBS lead placement with Brigham and Women's Hospital (2024)

## Products & services

- **Portable MRI-Compatible Surgical Robot** — A compact, portable robotic platform designed to operate inside the MRI bore, providing actuated instrument alignment and continuous, real-time MRI visualization during neurosurgery. It integrates into existing clinical workflows in MRI suites and operating rooms.
- **MRI-Guided Deep Brain Stimulation (DBS) Lead Placement** — Robot-assisted, real-time MRI-guided placement of neurostimulation leads for patients with Parkinson's disease and other functional brain disorders, aiming for millimeter-scale precision and reduced procedural variability.
- **Cranial Intervention Suite** — Expanded applications of the platform including MRI-guided biopsy, tumor ablation, epilepsy ablation, and targeted intracranial delivery of therapeutics.
- **Siemens MAGNETOM Software Interface** — A software interface developed with Siemens Healthineers enabling the robot to exchange data and operate with Siemens MAGNETOM MRI scanners (0.55T, 1.5T, 3T, including MAGNETOM Free.XL).

## Achievements

- Developed the first MRI-compatible surgical robot to enter human clinical trials for in-bore neurosurgery
- Closed $8.1M Series A in September 2025; ~$13.1M total funding raised
- Completed cadaver trial for bilateral DBS lead placement with Brigham and Women's Hospital (2024)
- Signed collaboration agreement with Siemens Healthineers for MAGNETOM MRI integration (2026)
- Added surgical-robotics pioneer Dr. Yulun Wang to its board (2026)
- Backed by a $3M NIH award for robotic brain-cancer treatment via founder's WPI lab

## Latest updates

- **2026-05** — Announced collaboration agreement with Siemens Healthineers to integrate the robot with MAGNETOM MRI scanners.
- **2026-03** — Appointed surgical-robotics pioneer Dr. Yulun Wang to its board of directors ahead of commercial launch.
- **2025-09** — Closed $8.1M Series A led by IQ Capital and 1540 Ventures to advance MRI-compatible surgical robotics.
- **2024-05** — Partnered with Brigham and Women's Hospital; performed cadaver trial of MRI-guided bilateral DBS lead placement at WPI's PracticePoint.

## Links

- Website: https://aimmedicalrobotics.com
- LinkedIn: https://www.linkedin.com/company/aim-medical-robotics
- YouTube: https://www.youtube.com/@aimmedicalrobotics

---

Profile page: https://yespress.io/aim-medical-robotics
Published by YesPress — https://yespress.io
Last updated: 2026-07-22